MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,000 | -42.9% | 1,060 | 0.0% | 0.00% | – |
| Q3 2016 | $7,000 | -36.4% | 1,060 | -48.5% | 0.00% | – |
| Q2 2016 | $11,000 | -35.3% | 2,060 | +3.0% | 0.00% | -100.0% |
| Q1 2016 | $17,000 | +6.2% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $16,000 | +77.8% | 2,000 | +100.0% | 0.00% | 0.0% |
| Q3 2015 | $9,000 | -25.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $12,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $12,000 | +9.1% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $11,000 | +22.2% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $9,000 | +28.6% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $7,000 | -30.0% | 1,000 | -50.0% | 0.00% | 0.0% |
| Q1 2014 | $10,000 | +100.0% | 2,000 | +100.0% | 0.00% | 0.0% |
| Q4 2013 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $4,000 | -42.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,244,080 | $12,096,000 | 4.51% |
| ALTFEST L J & CO INC | 39,491 | $1,653,000 | 1.15% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $446,000 | 0.44% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,074,557 | $48,912,000 | 0.40% |
| Virtus ETF Advisers LLC | 87,477 | $472,000 | 0.35% |
| Cannell & Co. | 1,614,678 | $8,703,000 | 0.32% |
| Birchview Capital, LP | 44,000 | $237,000 | 0.17% |
| STONERIDGE INVESTMENT PARTNERS LLC | 180,534 | $973,000 | 0.14% |
| HighPoint Advisor Group LLC | 8,484 | $344,000 | 0.12% |
| MARINER INVESTMENT GROUP LLC | 63,090 | $340,000 | 0.12% |